| Revenues, EBT, and Assets for reportable segments |
The table below presents revenues, EBT and total assets for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|
March 29,
2020 |
|
March 31,
2019 |
|
March 29,
2020 |
|
March 31,
2019 |
| Revenues |
|
|
|
|
|
|
|
| QCT |
$ |
4,100 |
|
|
$ |
3,722 |
|
|
$ |
7,719 |
|
|
$ |
7,461 |
|
| QTL |
1,072 |
|
|
1,122 |
|
|
2,477 |
|
|
2,141 |
|
| QSI |
10 |
|
|
98 |
|
|
30 |
|
|
125 |
|
| Reconciling items |
34 |
|
|
40 |
|
|
66 |
|
|
97 |
|
| Total |
$ |
5,216 |
|
|
$ |
4,982 |
|
|
$ |
10,292 |
|
|
$ |
9,824 |
|
| EBT |
|
|
|
|
|
|
|
| QCT |
$ |
667 |
|
|
$ |
542 |
|
|
$ |
1,145 |
|
|
$ |
1,140 |
|
| QTL |
671 |
|
|
674 |
|
|
1,689 |
|
|
1,264 |
|
| QSI |
(208) |
|
|
17 |
|
|
(210) |
|
|
25 |
|
| Reconciling items |
(532) |
|
|
(427) |
|
|
(1,079) |
|
|
(1,063) |
|
| Total |
$ |
598 |
|
|
$ |
806 |
|
|
$ |
1,545 |
|
|
$ |
1,366 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 29,
2020 |
|
September 29,
2019 |
| Assets |
|
|
|
| QCT |
$ |
3,286 |
|
|
$ |
2,307 |
|
| QTL |
1,465 |
|
|
1,541 |
|
| QSI |
1,281 |
|
|
1,708 |
|
| Reconciling items |
25,906 |
|
|
27,401 |
|
| Total |
$ |
31,938 |
|
|
$ |
32,957 |
|
|
| Reconciling items for reportable segments - revenues |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|
March 29,
2020 |
|
March 31,
2019 |
|
March 29,
2020 |
|
March 31,
2019 |
| Revenues |
|
|
|
|
|
|
|
| Nonreportable segments |
$ |
34 |
|
|
$ |
40 |
|
|
$ |
66 |
|
|
$ |
97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
34 |
|
|
$ |
40 |
|
|
$ |
66 |
|
|
$ |
97 |
|
| EBT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unallocated cost of revenues |
$ |
(84) |
|
|
$ |
(104) |
|
|
$ |
(175) |
|
|
$ |
(218) |
|
| Unallocated research and development expenses |
(216) |
|
|
(190) |
|
|
(475) |
|
|
(337) |
|
| Unallocated selling, general and administrative expenses |
(56) |
|
|
(84) |
|
|
(172) |
|
|
(148) |
|
| Unallocated other income (expenses) (Note 2) |
23 |
|
|
18 |
|
|
23 |
|
|
(130) |
|
| Unallocated interest expense |
(145) |
|
|
(159) |
|
|
(293) |
|
|
(313) |
|
| Unallocated investment and other (expense) income, net |
(30) |
|
|
109 |
|
|
52 |
|
|
130 |
|
| Nonreportable segments |
(24) |
|
|
(17) |
|
|
(39) |
|
|
(47) |
|
|
|
|
|
|
|
|
|
|
$ |
(532) |
|
|
$ |
(427) |
|
|
$ |
(1,079) |
|
|
$ |
(1,063) |
|
|
| Reconciling items for reportable segments - EBT |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|
March 29,
2020 |
|
March 31,
2019 |
|
March 29,
2020 |
|
March 31,
2019 |
| Revenues |
|
|
|
|
|
|
|
| Nonreportable segments |
$ |
34 |
|
|
$ |
40 |
|
|
$ |
66 |
|
|
$ |
97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
34 |
|
|
$ |
40 |
|
|
$ |
66 |
|
|
$ |
97 |
|
| EBT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unallocated cost of revenues |
$ |
(84) |
|
|
$ |
(104) |
|
|
$ |
(175) |
|
|
$ |
(218) |
|
| Unallocated research and development expenses |
(216) |
|
|
(190) |
|
|
(475) |
|
|
(337) |
|
| Unallocated selling, general and administrative expenses |
(56) |
|
|
(84) |
|
|
(172) |
|
|
(148) |
|
| Unallocated other income (expenses) (Note 2) |
23 |
|
|
18 |
|
|
23 |
|
|
(130) |
|
| Unallocated interest expense |
(145) |
|
|
(159) |
|
|
(293) |
|
|
(313) |
|
| Unallocated investment and other (expense) income, net |
(30) |
|
|
109 |
|
|
52 |
|
|
130 |
|
| Nonreportable segments |
(24) |
|
|
(17) |
|
|
(39) |
|
|
(47) |
|
|
|
|
|
|
|
|
|
|
$ |
(532) |
|
|
$ |
(427) |
|
|
$ |
(1,079) |
|
|
$ |
(1,063) |
|
|